FI940850A - Laite lääkkeen annostelemiseksi ihon kautta - Google Patents

Laite lääkkeen annostelemiseksi ihon kautta Download PDF

Info

Publication number
FI940850A
FI940850A FI940850A FI940850A FI940850A FI 940850 A FI940850 A FI 940850A FI 940850 A FI940850 A FI 940850A FI 940850 A FI940850 A FI 940850A FI 940850 A FI940850 A FI 940850A
Authority
FI
Finland
Prior art keywords
drug delivery
transdermal drug
transdermal
delivery
drug
Prior art date
Application number
FI940850A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI940850A0 (fi
Inventor
Renee A Fallon
Subbu S Venkatraman
Gary W Cleary
Original Assignee
Cygnus Therapeutic Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cygnus Therapeutic Systems filed Critical Cygnus Therapeutic Systems
Publication of FI940850A0 publication Critical patent/FI940850A0/fi
Publication of FI940850A publication Critical patent/FI940850A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI940850A 1991-08-23 1994-02-23 Laite lääkkeen annostelemiseksi ihon kautta FI940850A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/748,935 US5273756A (en) 1991-08-23 1991-08-23 Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
PCT/US1992/006839 WO1993003692A1 (en) 1991-08-23 1992-08-14 Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset

Publications (2)

Publication Number Publication Date
FI940850A0 FI940850A0 (fi) 1994-02-23
FI940850A true FI940850A (fi) 1994-03-09

Family

ID=25011540

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940850A FI940850A (fi) 1991-08-23 1994-02-23 Laite lääkkeen annostelemiseksi ihon kautta

Country Status (10)

Country Link
US (1) US5273756A (no)
EP (1) EP0600023A4 (no)
JP (1) JPH06510043A (no)
AU (1) AU670410B2 (no)
CA (1) CA2115570A1 (no)
FI (1) FI940850A (no)
NO (1) NO940589L (no)
NZ (1) NZ244000A (no)
PT (1) PT100807A (no)
WO (1) WO1993003692A1 (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679399A (en) 1987-07-17 1997-10-21 Bio Barrier, Inc. Method of forming a membrane, especially a latex or polymer membrane, including multiple discrete layers
US5549924A (en) 1987-07-17 1996-08-27 Robin Renee Thill Shlenker Method of forming a membrane, especially a latex or polymer membrane, including a deactivating barrier and indicating layer
AU6957594A (en) * 1993-05-26 1994-12-20 Becton Dickinson & Company Patch, with system and apparatus for manufacture
DE4341444C2 (de) * 1993-12-04 1996-03-14 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung
CH686928A5 (fr) * 1993-12-17 1996-08-15 Westonbridge Int Ltd Pansement adhésif pour l'administration transdermique d'un médicament.
US5635203A (en) * 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
US5814031A (en) * 1995-03-02 1998-09-29 Mooney; Mark Structured occllusive dressings
AU5543196A (en) * 1995-04-12 1996-10-30 Robert B. Hopp Skin patch for use in contact immunotherapy
US5730721A (en) 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
US6337328B1 (en) 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
ES2239196T3 (es) * 2002-12-02 2005-09-16 Schwarz Pharma Ag Suministro iontoforetico de rotigotina para el tratamiento de la enfermedad de parkinson.
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
CA2544291C (en) 2003-10-27 2013-01-08 University Of Basel Transdermal drug delivery method and system
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
CA2603851A1 (en) * 2005-04-11 2006-10-19 The Board Of Trustees Of The Leland Stanford Junior Unversity Multi-layer structure having a predetermined layer pattern including an agent
WO2006127905A2 (en) 2005-05-24 2006-11-30 Chrono Therapeutics, Inc. Portable drug delivery device
WO2006135785A2 (en) * 2005-06-10 2006-12-21 Medical College Of Georgia Research Institute Compositions and methods for treating immune disorders
US9446017B2 (en) 2005-08-11 2016-09-20 Augusta University Research Institute, Inc. Compositions and methods for treating herpes simplex virus
EP1991113B1 (en) 2006-02-27 2014-08-20 Edwards Lifesciences Corporation Flux limiting membrane for intravenous amperometric biosensor
AU2006343077B2 (en) * 2006-05-08 2012-11-08 Teikoku Seiyaku Co., Ltd. Tansdermally absorbable preparation comprising anti-dementia agent
US9114133B2 (en) 2006-08-25 2015-08-25 U.S. Dept. Of Veterans Affairs Method of improving diastolic dysfunction
NZ582565A (en) 2007-07-10 2012-07-27 Agile Therapeutics Inc Dermal delivery device with in situ seal
US20130017188A1 (en) 2009-07-31 2013-01-17 The Brigham And Women's Hospital, Inc. Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses
CA2794565C (en) 2010-04-08 2018-08-21 Emory University Substituted androst-4-ene diones
CA2830069C (en) 2011-03-20 2019-11-12 The University Of British Columbia Therapeutic agent for emphysema and copd
US9480696B2 (en) 2011-05-04 2016-11-01 Trustees Of Boston University Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria
US20140227293A1 (en) 2011-06-30 2014-08-14 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
CA2841785A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
EP2543370A1 (en) 2011-07-06 2013-01-09 Georgia Health Sciences University Research Institute, Inc. Compositions and Methods for Treating Herpes Simplex Virus
US9243037B2 (en) 2011-11-10 2016-01-26 Trustees Of Boston College Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
US20150366890A1 (en) 2013-02-25 2015-12-24 Trustees Of Boston University Compositions and methods for treating fungal infections
EP3036226B1 (en) 2013-08-22 2020-01-08 The General Hospital Corporation Inhibitors of human 12/15-lipoxygenase
WO2015031765A2 (en) 2013-08-29 2015-03-05 Trustees Of Boston University Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections
EP3250258A4 (en) 2015-01-28 2018-09-05 Chrono Therapeutics, Inc. Drug delivery methods and systems
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
WO2016196664A1 (en) 2015-06-01 2016-12-08 Cedars-Sinai Medical Center Methods and use of compounds that bind to rela of nf-kb
BR112018001441A2 (pt) 2015-07-28 2018-09-11 Vyome Biosciences Pvt Ltd antibacterianos terapêuticos e profiláticos
JP2020503950A (ja) 2017-01-06 2020-02-06 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 経皮薬剤送達の装置及び方法
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
US4650484A (en) * 1983-02-03 1987-03-17 Alza Corporation Method for treating ischemic conditions
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
AT387394B (de) * 1983-06-03 1989-01-10 Isovolta Verfahren zur polykondensation von diphenolen und dicarbonsaeurehalogeniden
JPS60225143A (ja) * 1984-04-20 1985-11-09 Konishiroku Photo Ind Co Ltd ハロゲン化銀写真感光材料
US4786282A (en) * 1985-02-26 1988-11-22 Adria Laboratories Bandage for the topical administration of controlled amounts of nitroglycerin ointment
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
US4681584A (en) * 1985-05-03 1987-07-21 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
DE3518707A1 (de) * 1985-05-24 1986-11-27 Beiersdorf Ag, 2000 Hamburg Nitro-pflaster
JPS61293911A (ja) * 1985-06-24 1986-12-24 Teisan Seiyaku Kk 徐放化製剤
US4655766A (en) * 1985-08-01 1987-04-07 Alza Corporation Fluid imbibing pump with self-regulating skin patch
DE3617158C2 (de) * 1986-05-22 1994-10-06 Lohmann Therapie Syst Lts Transdermales Arzneimittel
US4784857A (en) * 1986-06-03 1988-11-15 Smith And Nephew Associated Companies Plc Drug delivery device, its preparation and use
US4917676A (en) * 1986-11-20 1990-04-17 Ciba-Geigy Corporation User-activated transdermal therapeutic system
US4956181A (en) * 1987-05-08 1990-09-11 Eastman Kodak Nitrate therapy for angina pectoris
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
US5073539A (en) * 1990-01-22 1991-12-17 Ciba-Geigy Corporation Transdermal administration of zwitterionic drugs
US5273755A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset
US5234690A (en) * 1991-08-23 1993-08-10 Cygnus Therapeutic Systems Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset

Also Published As

Publication number Publication date
WO1993003692A1 (en) 1993-03-04
AU2503792A (en) 1993-03-16
AU670410B2 (en) 1996-07-18
CA2115570A1 (en) 1993-03-04
PT100807A (pt) 1994-05-31
EP0600023A1 (en) 1994-06-08
NO940589L (no) 1994-04-13
US5273756A (en) 1993-12-28
NO940589D0 (no) 1994-02-21
JPH06510043A (ja) 1994-11-10
NZ244000A (en) 1995-04-27
FI940850A0 (fi) 1994-02-23
EP0600023A4 (en) 1995-06-14

Similar Documents

Publication Publication Date Title
FI940850A (fi) Laite lääkkeen annostelemiseksi ihon kautta
DK0559736T3 (da) Lægemiddeldispenseringsindretning
IL86076A0 (en) Transdermal drug delivery device
KR950703383A (ko) 초음파 경피약제전달 시스템(ultrasonic transdermal drug delivery system)
PT101106A (pt) Dispositivo administrador
FI103379B1 (fi) Yksikköannostussovitelma
NO950725D0 (no) Trykket transdermal medikamentavleveringsinnretning
DE69203990D1 (de) Einrichtung zur transdermalen Verabreichung von Medikamenten.
NO920067D0 (no) Foradditiv for droevtyggere
DE69316999D1 (de) Abgabevorrichtung
DE69224941D1 (de) Arzneimittelabgabekatheter
ZA919761B (en) Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
FI956271A0 (fi) Lääkeaineen täyttölaite
FI912520A (fi) Leikkaustoimenpidelaite
EE04006B1 (et) Transkorneaalne seade ravimite kontrollitavaks manustamiseks
DE69133445D1 (de) Arzneistoffabgabesystem
DE69218932D1 (de) Transdermale therapeutische Formulierung
DE69219726D1 (de) Intravenöse dosierungen überwachende vorrichtung
NO923859D0 (no) Medikament
DK0507513T3 (da) Terapeutisk anordning
DE69208477D1 (de) Abgabevorrichtung
DE69224757D1 (de) Unabhängige infusionsvorrichtung
DE69128314D1 (de) Vorrichtung zur transdermalen Arzneimittelabgabe
IT217359Z2 (it) Dispositivo di somministrazione di farmaci
DE59206014D1 (de) Fadenliefervorrichtung

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: CYGNUS, INC.

FD Application lapsed